Auto Amazon Links: No products found. Blocked by captcha.
Recent data from the UK reveals a significant decline in cancer mortality rates, reaching the lowest levels ever recorded. Between 2022 and 2024, approximately 247 individuals per 100,000 lost their lives to cancer annually, representing a sharp reduction from the peak of 355 per 100,000 observed in 1989. This nearly 29% decrease is credited to sustained investments in cancer research, prevention efforts, and advancements in treatment over the past several decades.
The improvement is largely driven by notable decreases in death rates from several prevalent cancers. Over the last ten years, stomach cancer fatalities dropped by 34%, lung cancer by 22%, ovarian cancer by 19%, breast cancer by 14%, and prostate cancer by 11%. Enhanced screening programs, earlier diagnosis, and new therapeutic options have all contributed to these encouraging trends. For example, hormone-based therapies have played a key role in reducing prostate cancer deaths, while cervical cancer mortality has plummeted by 75% since the 1970s due to effective national screening and the implementation of the HPV vaccine.
Screening initiatives have been a cornerstone in this progress, with the NHS cervical screening program detecting cancers at early stages and often identifying precancerous changes. The HPV vaccine, introduced in 2008 and now widely administered, has further prevented infections linked to cervical cancer development. Screening efforts for breast and colorectal cancers have also improved early detection, and PSA testing has enhanced prostate cancer diagnosis. Alongside these preventive measures, advances in personalised medicine, targeted therapies, and immunotherapy are offering more tailored and effective treatment options. Researchers are even exploring vaccines that could potentially prevent cancers such as lung and ovarian in the future.
However, despite the overall reduction in age-standardised mortality rates, the absolute number of cancer deaths is increasing due to population growth and longer life expectancy. Age-related cellular damage raises cancer risk over time, which has led to heightened research focus on cancers frequently diagnosed at late stages and harder to treat. Some cancer types are experiencing rising death rates, including skin, intestinal, bone, gallbladder, and eye cancers, alongside liver and kidney cancers. Factors such as difficulty in early detection, limited treatment availability, and lifestyle choices may explain these rises. Still, experts remain optimistic that continued investment in research, screening, and healthcare capacity could drive cancer death rates down by about 6% within the next twenty years
Read the full article on Positive News here: Read More
Auto Amazon Links: No products found. Blocked by captcha.